tm logo

Monitor this mark

View On USPTO

ERSYNGA
Live/Pending
THIRD EXTENSION - GRANTED

granted

on 25 Oct 2024

Last Applicant/ Owned by

Johnson & Johnson

One Johnson & Johnson Plaza

New Brunswick

NJ

08933

Serial Number

97396189 filed on 05th May 2022

Registration Number

N/A

Correspondent Address

Danielle R. Weitzman

Danielle R. Weitzman Johnson & Johnson

New Brunswick, NJ 08933

United States

Filing Basis

1. intent to use

2. intent to use current

Disclaimer

NO DATA

ERSYNGA

Pharmaceutical preparations for the treatment of oncological diseases and disorders

Classification Information

Class [005]
Pharmaceutical Products

Pharmaceutical preparations for the treatment of oncological diseases and disorders

First Use Date in General

N/A

First Use Date in Commerce

N/A

Mark Details

Serial Number

No 97396189

Mark Type

No Service/Collective Mark

Attorney Docket Number

No T44241US2

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History

Show more

Status DateAction Taken
25th Oct 2024SOU EXTENSION 3 GRANTED
25th Oct 2024SOU EXTENSION 3 FILED
25th Oct 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
25th Oct 2024SOU TEAS EXTENSION RECEIVED
18th Apr 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
17th Apr 2024SOU EXTENSION 2 GRANTED
17th Apr 2024SOU EXTENSION 2 FILED
17th Apr 2024SOU TEAS EXTENSION RECEIVED
13th Oct 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
11th Oct 2023SOU EXTENSION 1 GRANTED